Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Onyx Biotec Limited (NSE: ONYX), ISIN INE0WVU01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ONYX last traded at ₹35.50 (-1.66%), with a 52-week range of ₹24.20 to ₹49.65 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 65.10%, FIIs 1.07%, DIIs 2.39%, mutual funds 0.00%.
EquiSense Score (ECS): 44/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.